Preconditioning with the prostacyclin analog epoprostenol and cobra venom factor prevents reperfusion injury and hyperacute rejection in discordant liver xenotransplantation-Reference-Cited by-同舟云学术

Preconditioning with the prostacyclin analog epoprostenol and cobra venom factor prevents reperfusion injury and hyperacute rejection in discordant liver xenotransplantation

Published:2001-02 Issue:1 Volume:8 Page:41-47
ISSN:0908-665X
Container-title:Xenotransplantation
language:en
Short-container-title:

Author:

Meyer zu Vilsendorf Andreas,Link Claudia,Jörns Anne,Nagel Eckhard,Köhl Jörg

Publisher

Wiley

Subject

Transplantation,Immunology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1399-3089.2001.00074.x/fullpdf

Reference24 articles.

1. Effects of leflunomide and deoxyspergualin in the guinea pig → rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin;Hancock;Transplantation,1997

2. Limitations to the feasibility of discordant liver transplantation;Schraa;Transplant Proc,1996

3. IgG, but not IgM, mediates hyperacute rejection in hepatic xenografting;Schraa;Xenotransplantation,1999

4. Basic anatomical and physiological differences between species should be considered when choosing combinations for use in models of hepatic xenotransplantation;Delriviere;Transplant-ation,1998

5. Impaired recolor-ation of a discordant liver xenograft in the guinea pig-to-rat combination;Tanaka;Transplantation,1999

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Xenotransplantation: Current Challenges and Emerging Solutions;Cell Transplantation;2023-01

2. Impaired endothelium-dependent and endothelium-independent systemic vasodilatory reserve in pulmonary hypertension regardless the clinical group: A generalized dysfunction beyond the pulmonary arteries?;The Anatolian Journal of Cardiology;2021-10-06

3. Translational strategies to minimize transfusion requirement in liver surgery and transplantation: Targeting ischemia-reperfusion injury;Transfusion-Free Medicine and Surgery;2014-08-01

4. Liver Ischemia/Reperfusion Injury: an Overview;Journal of Investigative Surgery;2014-07-24

5. Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration;Journal of Surgical Research;2014-04